Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-07-055856
Filing Date
2007-03-16
Accepted
2007-03-15 18:29:55
Documents
8
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1172310
2 LETTER AGREEMENT dex1058.htm EX-10.58 7194
3 AMENDMENT TO THE LORIA LICENSE dex1059.htm EX-10.59 112069
4 CONSENT OF BDO SEIDMAN, LLP dex231.htm EX-23.1 3246
5 CERTIFICATION OF RICHARD B. HOLLIS dex311.htm EX-31.1 10142
6 CERTIFICATION OF DANIEL D. BURGESS dex312.htm EX-31.2 10268
7 SECTION 1350 CERTIFICATIONS OF RICHARD B. HOLLIS AND DANIEL D. BURGESS dex321.htm EX-32.1 6142
8 GRAPHIC g62378g45l47.jpg GRAPHIC 51453
  Complete submission text file 0001193125-07-055856.txt   1393952
Mailing Address 4435 EASTGATE MALL SUITE 400 SAN DIEGO CA 92121
Business Address 4435 EASTGATE MALL SUITE 400 SAN DIEGO CA 92121 858-587-9333
HOLLIS EDEN PHARMACEUTICALS INC /DE/ (Filer) CIK: 0000899394 (see all company filings)

EIN.: 133697002 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-24672 | Film No.: 07697668
SIC: 2834 Pharmaceutical Preparations